In a national RAND survey, nearly half of recent psilocybin mushroom users said their last session was a microdose. That single choice explains why benefit claims now travel faster than the trials meant to test them. People want calmer days, easier focus, and more flexible thinking without a full psychedelic experience. Those reports deserve a … Read more